RUMORED BUZZ ON CHIR-090

CRC has an immunosuppressive TME which helps prevent the development of a powerful response to ICB therapies. You can find Hence an urgent have to establish the approaches reprogram this suppressive TME in order to enrich immunotherapy efficacy. In the current review, we used CRISPR KO screens to find genes that sensitize CRC to antitumor immunity